{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:42:34Z","timestamp":1790026954211,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"STW-NWO VENI","award":["11878"],"award-info":[{"award-number":["11878"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["644373"],"award-info":[{"award-number":["644373"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jconrel.2016.03.014","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T07:36:40Z","timestamp":1458027400000},"page":"93-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"special_numbering":"C","title":["EGFR targeted nanobody\u2013photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer"],"prefix":"10.1016","volume":"229","author":[{"given":"Pieter B.A.A.","family":"van Driel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime D.","family":"Slooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimond","family":"Heukers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke A.","family":"Stammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.A.","family":"Snoeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette S.","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.P.","family":"van Bergen en Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.H.","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens W.G.M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-2122","authenticated-orcid":false,"given":"Sabrina","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.03.014_bb0005","series-title":"Globocan 2012: Estimated Cancer Incidence, Mortatlity and Prevalence Worldwide in 2012","author":"I.A.f.R.o.C.W.H. Organisation","year":"2012"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bjoms.2012.11.011","article-title":"Photodynamic therapy in the management of lesions of the head and neck","volume":"51","author":"Green","year":"2013","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hed.21969","article-title":"mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: development of a new method","volume":"34","author":"Karakullukcu","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1751-1097.2009.00585.x","article-title":"Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy","volume":"85","author":"O'Connor","year":"2009","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1572-1000(04)00007-9","article-title":"Photosensitizers in clinical PDT","volume":"1","author":"Allison","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pdpdt.2010.02.001","article-title":"Oncologic photodynamic therapy photosensitizers: a clinical review","volume":"7","author":"Allison","year":"2010","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1751-1097.1991.tb02133.x","article-title":"Preclinical examination of first and second generation photosensitizers used in photodynamic therapy","volume":"54","author":"Gomer","year":"1991","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2003.07.014","article-title":"Liposomes for photodynamic therapy","volume":"56","author":"Derycke","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2003.09.003","article-title":"Photosensitizer\u2013antibody conjugates for detection and therapy of cancer","volume":"56","author":"van Dongen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0060","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/17425240802444673","article-title":"Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms","volume":"5","author":"Sibani","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2003.08.015","article-title":"Targeted photodynamic therapy via receptor mediated delivery systems","volume":"56","author":"Sharman","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0070","first-page":"4490","article-title":"Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo","volume":"61","author":"Soukos","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cncr.22402","article-title":"Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors","volume":"109","author":"Beckman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0085","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.106.037069","article-title":"Theoretic criteria for antibody penetration into solid tumors and micrometastases","volume":"48","author":"Thurber","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1562\/2006-04-02-RA-865","article-title":"In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane","volume":"82","author":"Bronshteint","year":"2006","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0095","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjc.1997.149","article-title":"Biodistribution of charged F(ab\u2032)2 photoimmunoconjugates in a xenograft model of ovarian cancer","volume":"75","author":"Duska","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1039\/b708320c","article-title":"Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosensitizer conjugates suitable for photodynamic therapy","volume":"6","author":"Kuimova","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2567.2006.02522.x","article-title":"Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer","volume":"120","author":"Staneloudi","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0110","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ijc.23206","article-title":"Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments","volume":"122","author":"Bhatti","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3184\/003685008X361415","article-title":"Towards recombinant antibody-fragment targeted photodynamic therapy","volume":"91","author":"Milgrom","year":"2008","journal-title":"Sci. Prog."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnumed.114.149526","article-title":"Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?","volume":"56","author":"Watanabe","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0125","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.nano.2013.12.007","article-title":"Nanobody-photosensitizer conjugates for targeted photodynamic therapy","volume":"10","author":"Heukers","year":"2014","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2013.08.298","article-title":"Targeting tumors with nanobodies for cancer imaging and therapy","volume":"172","author":"Oliveira","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Protein Eng."},{"issue":"2013","key":"10.1016\/j.jconrel.2016.03.014_bb0150","article-title":"Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery","volume":"40","author":"Kijanka","year":"1718","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2310\/7290.2011.00025","article-title":"Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody","volume":"11","author":"Oliveira","year":"2012","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0160","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","article-title":"A modeling analysis of the effects of molecular size and binding affinity on tumor targeting","volume":"8","author":"Schmidt","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0165","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2967\/jnumed.107.048538","article-title":"Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT\/micro-CT","volume":"49","author":"Gainkam","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0170","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26145","article-title":"A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth","volume":"129","author":"Roovers","year":"2011","journal-title":"J. Int. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0175","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0180","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0185","series-title":"Phthalocyanine dye as an extremely photostable and highly fluorescent near-infrared labeling reagent","author":"Peng","year":"2006"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0190","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1242\/jcs.128611","article-title":"Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif","volume":"126","author":"Heukers","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0195","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural evaluation of EGFR inhibition mechanisms for nanobodies\/VHH domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-1656(99)00228-X","article-title":"Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae","volume":"78","author":"Frenken","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/prot.20378","article-title":"Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen","volume":"59","author":"Dolk","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0210","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/ijc.28601","article-title":"Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody","volume":"134","author":"van Driel","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0215","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2006"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/1011-1344(95)07241-1","article-title":"Photophysical and photochemical properties of potential porphyrin and chlorine photosensitizers for PDT","volume":"33","author":"Zenkevich","year":"1996","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0225","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/B:JAPS.0000016312.04644.c7","article-title":"Spectral-luminescent studies of the \u201cPhotolon\u201d photosensitizer in model media and in blood of oncological patients","volume":"70","author":"Parkhots","year":"2003","journal-title":"J. Appl. Spectrosc."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0230","series-title":"Molecular Probes Product Information","author":"Invitrogen","year":"2004"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0235","first-page":"113","article-title":"Quantum yields for the photosensitized formation of the lowest electronically excited singlet state of molecular oxygen in solution","volume":"22","author":"Wilkinson","year":"1993","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1751-1097.1999.tb08240.x","article-title":"A compilation of singlet oxygen yields from biologically relevant molecules","volume":"70","author":"Redmond","year":"1999","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2007.09.002","article-title":"Photosensitiser-loaded biodegradable polymeric micelles: preparation, characterisation and in vitro PDT efficacy","volume":"124","author":"Rijcken","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0250","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11095-008-9590-7","article-title":"Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation","volume":"25","author":"Hofman","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0255","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1364\/BOE.4.000696","article-title":"In vivo quantification of the scattering properties of tissue using multi-diameter single fiber reflectance spectroscopy","volume":"4","author":"van Leeuwen-van Zaane","year":"2013","journal-title":"Biomed. Opt. Expr."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0260","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1117\/1.JBO.19.1.015010","article-title":"Intrinsic photosensitizer fluorescence measured using multi-diameter single-fiber spectroscopy in vivo","volume":"19","author":"van Leeuwen-van Zaane","year":"2014","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0265","doi-asserted-by":"crossref","first-page":"57002","DOI":"10.1117\/1.JBO.20.5.057002","article-title":"Sources of variability in the quantification of tissue optical properties by multidiameter single-fiber reflectance and fluorescence spectroscopy","volume":"20","author":"Brooks","year":"2015","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0270","doi-asserted-by":"crossref","first-page":"107005","DOI":"10.1117\/1.JBO.18.10.107005","article-title":"Method for rapid multidiameter single-fiber reflectance and fluorescence spectroscopy through a fiber bundle","volume":"18","author":"Hoy","year":"2013","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/bp00013a006","article-title":"Antibody-targeted photolysis: in vitro immunological, photophysical, and cytotoxic properties of monoclonal antibody-dextran-Sn(IV) chlorin e6 immunoconjugates","volume":"8","author":"Rakestraw","year":"1992","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0280","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.130.3.1473","article-title":"Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates","volume":"130","author":"Mew","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0285","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1054\/bjoc.2001.2170","article-title":"Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates","volume":"85","author":"Carcenac","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0290","first-page":"1505","article-title":"Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy","volume":"59","author":"Vrouenraets","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0295","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.03.014_bb0300","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1158\/1535-7163.MCT-08-0067","article-title":"Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids","volume":"7","author":"Ackerman","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1562\/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2","article-title":"Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates","volume":"77","author":"Savellano","year":"2003","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0310","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1078-0432.CCR-04-1902","article-title":"Photochemical targeting of epidermal growth factor receptor: a mechanistic study","volume":"11","author":"Savellano","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2012.01.014","article-title":"Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells","volume":"321","author":"Abu-Yousif","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2016.03.014_bb0320","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12265-012-9422-3","article-title":"von Willebrand factor inhibition improves endothelial function in patients with stable angina","volume":"6","author":"Muller","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:44:45Z","timestamp":1692254685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916301481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":64,"alternative-id":["S0168365916301481"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR targeted nanobody\u2013photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}